Lonza "not in crisis" as cost-cutting starts
This article was originally published in Scrip
Executive Summary
Swiss pharmaceutical ingredients supplier Lonza is in cost-cutting mode after a series of unexpected order cancellations and postponements within the last month sent its earnings guidance for the year south.